Durability of Response in Plaque Psoriasis Patients Treated with Certolizumab Pegol: Two Year Data from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

10-2019

Journal Title

Journal of the American Academy of Dermatology

Department

Dermatology

This document is currently not available here.

Share

COinS